![Mark W. Womack](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Mark W.
Womack is currently Chief Executive Officer at Selexis SA since 2022.
Formerly, Mr. Womack was Chief Executive Officer at KBI Biopharma, Inc. from 2022 to 2023, Chief Executive Officer at OneSource Specialty Pharma Ltd., Chief Executive Officer at BioCina Pty Ltd. from 2023 to 2025, and Chief Business Officer at AGC Biologics, Inc.
Actieve functies van Mark W. Womack
| Bedrijven | Functie | Begin |
|---|---|---|
Selexis SA
 Selexis SA Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the field of mammalian cell lines | Algemeen Directeur | 02-05-2022 |
Eerdere bekende functies van Mark W. Womack
| Bedrijven | Functie | Einde |
|---|---|---|
KBI Biopharma, Inc.
 KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Algemeen Directeur | 17-04-2023 |
| ONESOURCE SPECIALTY PHARMA LIMITED | Algemeen Directeur | - |
AGC Biologics, Inc.
 AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology Manufactures protein-based therapeutics | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
9
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug development and contract manufacturing services | Commercial Services |
AGC Biologics, Inc.
AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology Manufactures protein-based therapeutics | Health Technology |
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the field of mammalian cell lines | Commercial Services |
OneSource Specialty Pharma Ltd.
 OneSource Specialty Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures GLP-1 drugs & novel biologics | Health Technology |
